Paper by Laura Magazzini, Fabio Pammolli and Massimo Riccaboni among the Thomson Reuters' Highly Cited

1 September 2014
The paper on "The productivity crisis of pharmaceutical R&D" co-authored by Laura Magazzini, Fabio Pammolli and Massimo Riccaboni in "Nature Reviews Drug Discovery" (n. 10, June 2011) has been listed among the ISI-Thomson Reuters' Highly Cited Papers. Highly Cited Papers are defined as those that rank in the top 1% by citations for field and year of publication. These data derive from Essential Science Indicators? (ESI). Those researchers who, within an ESI-defined field, published Highly Cited Papers are judged to be influential by Thomson Reuters.